These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20046150)

  • 1. Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities.
    Nachega JB; Mills EJ; Schechter M
    Curr Opin HIV AIDS; 2010 Jan; 5(1):70-7. PubMed ID: 20046150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future management of treatment failure in low- and middle-income countries.
    Boyd MA
    Curr Opin HIV AIDS; 2010 Jan; 5(1):83-9. PubMed ID: 20046152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequencing of antiretroviral therapy in children in low- and middle-income countries.
    Sohn AH; Nuttall JJ; Zhang F
    Curr Opin HIV AIDS; 2010 Jan; 5(1):54-60. PubMed ID: 20046148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early versus deferred antiretroviral therapy in children in low-income and middle-income countries.
    Puthanakit T; Bunupuradah T
    Curr Opin HIV AIDS; 2010 Jan; 5(1):12-7. PubMed ID: 20046143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to optimize HIV treatment outcomes in resource-limited settings.
    Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
    AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence: a necessity for successful HIV combination therapy.
    Chesney MA; Ickovics J; Hecht FM; Sikipa G; Rabkin J
    AIDS; 1999; 13 Suppl A():S271-8. PubMed ID: 10885784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance considerations in sequencing of antiretroviral therapy in low-middle income countries with currently available options.
    De Luca A; Prosperi M; Bracciale L
    Curr Opin HIV AIDS; 2010 Jan; 5(1):27-37. PubMed ID: 20046145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving first-line antiretroviral therapy in resource-limited settings.
    Ford N; Calmy A
    Curr Opin HIV AIDS; 2010 Jan; 5(1):38-47. PubMed ID: 20046146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral drug resistance among HIV-1 infected children failing treatment.
    Mullen J; Leech S; O'Shea S; Chrystie IL; Du Mont G; Ball C; Sharland M; Cottam F; Zuckerman M; Rice P; Easterbrook P
    J Med Virol; 2002 Nov; 68(3):299-304. PubMed ID: 12226814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring for treatment failure in patients on first-line antiretroviral treatment in resource-constrained settings.
    Lynen L; Van Griensven J; Elliott J
    Curr Opin HIV AIDS; 2010 Jan; 5(1):1-5. PubMed ID: 20046141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvements in antiretroviral therapy outcomes over calendar time.
    Boyd MA
    Curr Opin HIV AIDS; 2009 May; 4(3):194-9. PubMed ID: 19532050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda.
    Kent DM; McGrath D; Ioannidis JP; Bennish ML
    Clin Infect Dis; 2003 Jul; 37(Suppl 1):S13-24. PubMed ID: 12822128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supportive relationships and medication adherence in HIV-infected, low-income Latinos.
    van Servellen G; Lombardi E
    West J Nurs Res; 2005 Dec; 27(8):1023-39. PubMed ID: 16275696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term immunological outcomes in treated HIV-infected individuals in high-income and low-middle income countries.
    Achhra AC; Phanuphak P; Amin J
    Curr Opin HIV AIDS; 2011 Jul; 6(4):258-65. PubMed ID: 21546834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda.
    Kiboneka A; Wangisi J; Nabiryo C; Tembe J; Kusemererwa S; Olupot-Olupot P; Joffres M; Anema A; Cooper CL; Montaner JS; Mills EJ
    AIDS; 2008 Nov; 22(18):2493-9. PubMed ID: 19005272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy in 1999 for antiretroviral-naive individuals with HIV infection.
    Fischl MA
    AIDS; 1999 Sep; 13 Suppl 1():S49-59. PubMed ID: 10546785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.